The stock of Guardian Pharmacy Services Inc (GRDN) has seen a -8.54% decrease in the past week, with a -7.89% drop in the past month, and a 9.70% flourish in the past quarter. The volatility ratio for the week is 7.28%, and the volatility levels for the past 30 days are at 6.42% for GRDN. The simple moving average for the past 20 days is -11.64% for GRDN’s stock, with a 3.92% simple moving average for the past 200 days.
Is It Worth Investing in Guardian Pharmacy Services Inc (NYSE: GRDN) Right Now?
Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GRDN is 22.72M, and currently, short sellers hold a 4.37% ratio of that floaft. The average trading volume of GRDN on May 22, 2025 was 93.33K shares.
GRDN) stock’s latest price update
Guardian Pharmacy Services Inc (NYSE: GRDN) has experienced a decline in its stock price by -16.75 compared to its previous closing price of 26.50. However, the company has seen a fall of -8.54% in its stock price over the last five trading days. businesswire.com reported 2025-05-20 that ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, consisting of 6,059,553 shares being offered by certain selling stockholders and 1,440,447 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the un.
Analysts’ Opinion of GRDN
Many brokerage firms have already submitted their reports for GRDN stocks, with Truist repeating the rating for GRDN by listing it as a “Buy.” The predicted price for GRDN in the upcoming period, according to Truist is $22 based on the research report published on October 21, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GRDN reach a price target of $21. The rating they have provided for GRDN stocks is “Outperform” according to the report published on October 21st, 2024.
GRDN Trading at -3.82% from the 50-Day Moving Average
After a stumble in the market that brought GRDN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.02% of loss for the given period.
Volatility was left at 6.42%, however, over the last 30 days, the volatility rate increased by 7.28%, as shares sank -6.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.72% upper at present.
During the last 5 trading sessions, GRDN fell by -8.54%, in comparison to the 20-day moving average, which settled at $24.97. In addition, Guardian Pharmacy Services Inc saw 8.88% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GRDN starting from COSLER STEVEN D, who purchase 7,000 shares at the price of $21.22 back on Nov 19 ’24. After this action, COSLER STEVEN D now owns 17,713 shares of Guardian Pharmacy Services Inc, valued at $148,540 using the latest closing price.
Salentine Thomas J Jr, the Director of Guardian Pharmacy Services Inc, purchase 35,714 shares at $14.00 during a trade that took place back on Sep 27 ’24, which means that Salentine Thomas J Jr is holding 35,714 shares at $499,996 based on the most recent closing price.
Stock Fundamentals for GRDN
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.2 for the gross margin
The net margin for Guardian Pharmacy Services Inc stands at -0.06. The total capital return value is set at -0.31.
Based on Guardian Pharmacy Services Inc (GRDN), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 7.84. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -21.56.
Currently, EBITDA for the company is -43.43 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 1.08. The receivables turnover for the company is 13.16for trailing twelve months and the total asset turnover is 3.84. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.14.
Conclusion
In a nutshell, Guardian Pharmacy Services Inc (GRDN) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
